{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T13:57:10Z","timestamp":1772373430193,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>One of the primary objectives in cancer research is to identify causal genomic alterations, such as somatic copy number variation (CNV) and somatic mutations, during tumor development. Many valuable studies lack genomic data to detect CNV; therefore, methods that are able to infer CNVs from gene expression data would help maximize the value of these studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We developed a framework for identifying recurrent regions of CNV and distinguishing the cancer driver genes from the passenger genes in the regions. By inferring CNV regions across many datasets we were able to identify 109 recurrent amplified\/deleted CNV regions. Many of these regions are enriched for genes involved in many important processes associated with tumorigenesis and cancer progression. Genes in these recurrent CNV regions were then examined in the context of gene regulatory networks to prioritize putative cancer driver genes. The cancer driver genes uncovered by the framework include not only well-known oncogenes but also a number of novel cancer susceptibility genes validated via siRNA experiments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>To our knowledge, this is the first effort to systematically identify and validate drivers for expression based CNV regions in breast cancer. The framework where the wavelet analysis of copy number alteration based on expression coupled with the gene regulatory network analysis, provides a blueprint for leveraging genomic data to identify key regulatory components and gene targets. This integrative approach can be applied to many other large-scale gene expression studies and other novel types of cancer data such as next-generation sequencing based expression (RNA-Seq) as well as CNV data.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1752-0509-5-121","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T18:18:26Z","timestamp":1312309106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Inferring causal genomic alterations in breast cancer using gene expression data"],"prefix":"10.1186","volume":"5","author":[{"given":"Linh M","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric E","family":"Schadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,1]]},"reference":[{"issue":"1-4","key":"725_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000184710","volume":"123","author":"SJ Hebbring","year":"2008","unstructured":"Hebbring SJ, Moyer AM, Weinshilboum RM: Sulfotransferase gene copy number variation: pharmacogenetics and function. Cytogenet Genome Res. 2008, 123 (1-4): 205-10. 10.1159\/000184710","journal-title":"Cytogenet Genome Res"},{"key":"725_CR2","volume-title":"Leukemia","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Downing JR: Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia. 2009,"},{"issue":"4","key":"725_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1373\/clinchem.2008.118554","volume":"55","author":"JB Overdevest","year":"2009","unstructured":"Overdevest JB, Theodorescu D, Lee JK: Utilizing the molecular gateway: the path to personalized cancer management. Clin Chem. 2009, 55 (4): 684-971. 10.1373\/clinchem.2008.118554","journal-title":"Clin Chem"},{"key":"725_CR4","volume-title":"Br J Cancer","author":"C Swanton","year":"2009","unstructured":"Swanton C, Caldas C: Molecular classification of solid tumours: towards pathway-driven therapeutics. Br J Cancer. 2009,"},{"issue":"6871","key":"725_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van 't Veer","year":"2002","unstructured":"van 't Veer LJ, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002, 415 (6871): 530-6. 10.1038\/415530a","journal-title":"Nature"},{"issue":"9460","key":"725_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(05)70933-8","volume":"365","author":"Y Wang","year":"2005","unstructured":"Wang Y, et al.: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005, 365 (9460): 671-9.","journal-title":"Lancet"},{"issue":"6","key":"725_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1056\/NEJMoa052933","volume":"355","author":"C Fan","year":"2006","unstructured":"Fan C, et al.: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006, 355 (6): 560-9. 10.1056\/NEJMoa052933","journal-title":"N Engl J Med"},{"issue":"4","key":"725_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, et al.: Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006, 98 (4): 262-72. 10.1093\/jnci\/djj052","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"725_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1158\/1078-0432.CCR-08-1791","volume":"15","author":"F Andre","year":"2009","unstructured":"Andre F, et al.: Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res. 2009, 15 (2): 441-51. 10.1158\/1078-0432.CCR-08-1791","journal-title":"Clin Cancer Res"},{"issue":"6","key":"725_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/gcc.20558","volume":"47","author":"PM Haverty","year":"2008","unstructured":"Haverty PM, et al.: High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer. 2008, 47 (6): 530-42. 10.1002\/gcc.20558","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"725_CR11","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/sj.onc.1208383","volume":"24","author":"M Heidenblad","year":"2005","unstructured":"Heidenblad M, et al.: Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications. Oncogene. 2005, 24 (10): 1794-801. 10.1038\/sj.onc.1208383","journal-title":"Oncogene"},{"issue":"20","key":"725_CR12","doi-asserted-by":"publisher","first-page":"12963","DOI":"10.1073\/pnas.162471999","volume":"99","author":"JR Pollack","year":"2002","unstructured":"Pollack JR, et al.: Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA. 2002, 99 (20): 12963-8. 10.1073\/pnas.162471999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"725_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2008.11.013","volume":"15","author":"G Hu","year":"2009","unstructured":"Hu G, et al.: MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell. 2009, 15 (1): 9-20. 10.1016\/j.ccr.2008.11.013","journal-title":"Cancer Cell"},{"issue":"6871","key":"725_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van 't Veer","year":"2002","unstructured":"van 't Veer LJ, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002, 415 (6871): 530-6. 10.1038\/415530a","journal-title":"Nature"},{"issue":"38","key":"725_CR15","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.1073\/pnas.0506230102","volume":"102","author":"LD Miller","year":"2005","unstructured":"Miller LD, et al.: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA. 2005, 102 (38): 13550-5. 10.1073\/pnas.0506230102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"725_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/gcc.20366","volume":"45","author":"A Bergamaschi","year":"2006","unstructured":"Bergamaschi A, et al.: Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer. 2006, 45 (11): 1033-40. 10.1002\/gcc.20366","journal-title":"Genes Chromosomes Cancer"},{"issue":"7239","key":"725_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA: The cancer genome. Nature. 2009, 458 (7239): 719-24. 10.1038\/nature07943","journal-title":"Nature"},{"issue":"4","key":"725_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1101\/gr.101956.109","volume":"20","author":"A Torkamani","year":"2010","unstructured":"Torkamani A, et al.: Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res. 2010, 20 (4): 403-12. 10.1101\/gr.101956.109","journal-title":"Genome Res"},{"issue":"2","key":"725_CR19","doi-asserted-by":"publisher","first-page":"e8918","DOI":"10.1371\/journal.pone.0008918","volume":"5","author":"E Cerami","year":"2010","unstructured":"Cerami E, et al.: Automated network analysis identifies core pathways in glioblastoma. PLoS ONE. 2010, 5 (2): e8918- 10.1371\/journal.pone.0008918","journal-title":"PLoS ONE"},{"key":"725_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2164-7-125","volume":"7","author":"DC Kulp","year":"2006","unstructured":"Kulp DC, Jagalur M: Causal inference of regulator-target pairs by gene mapping of expression phenotypes. BMC Genomics. 2006, 7: 125- 10.1186\/1471-2164-7-125","journal-title":"BMC Genomics"},{"issue":"Suppl 1","key":"725_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1471-4159.2006.03661.x","volume":"97","author":"PY Lum","year":"2006","unstructured":"Lum PY, et al.: Elucidating the murine brain transcriptional network in a segregating mouse population to identify core functional modules for obesity and diabetes. J Neurochem. 2006, 97 (Suppl 1): 50-62.","journal-title":"J Neurochem"},{"issue":"11","key":"725_CR22","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/ng1619","volume":"37","author":"M Mehrabian","year":"2005","unstructured":"Mehrabian M, et al.: Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet. 2005, 37 (11): 1224-33. 10.1038\/ng1619","journal-title":"Nat Genet"},{"issue":"7","key":"725_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/ng1589","volume":"37","author":"EE Schadt","year":"2005","unstructured":"Schadt EE, et al.: An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet. 2005, 37 (7): 710-7. 10.1038\/ng1589","journal-title":"Nat Genet"},{"issue":"2-4","key":"725_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000078209","volume":"105","author":"J Zhu","year":"2004","unstructured":"Zhu J, et al.: An integrative genomics approach to the reconstruction of gene networks in segregating populations. Cytogenet Genome Res. 2004, 105 (2-4): 363-74. 10.1159\/000078209","journal-title":"Cytogenet Genome Res"},{"issue":"7","key":"725_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ng.167","volume":"40","author":"J Zhu","year":"2008","unstructured":"Zhu J, et al.: Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet. 2008, 40 (7): 854-61. 10.1038\/ng.167","journal-title":"Nat Genet"},{"issue":"4","key":"725_CR26","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1371\/journal.pcbi.0030069","volume":"3","author":"J Zhu","year":"2007","unstructured":"Zhu J, et al.: Increasing the Power to Detect Causal Associations by Combining Genotypic and Expression Data in Segregating Populations. PLoS Comput Biol. 2007, 3 (4): e69- 10.1371\/journal.pcbi.0030069","journal-title":"PLoS Comput Biol"},{"key":"725_CR27","volume-title":"Genome Res","author":"X Yang","year":"2010","unstructured":"Yang X, et al.: Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res. 2010,"},{"key":"725_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/msb4100129","volume":"3","author":"R Sharan","year":"2007","unstructured":"Sharan R, Ulitsky I, Shamir R: Network-based prediction of protein function. Mol Syst Biol. 2007, 3: 88-","journal-title":"Mol Syst Biol"},{"issue":"6","key":"725_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/jnci\/87.6.446","volume":"87","author":"N Roodi","year":"1995","unstructured":"Roodi N, et al.: Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst. 1995, 87 (6): 446-51. 10.1093\/jnci\/87.6.446","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"725_CR30","doi-asserted-by":"publisher","first-page":"9377","DOI":"10.1128\/MCB.01229-06","volume":"26","author":"SR Bartz","year":"2006","unstructured":"Bartz SR, et al.: Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol Cell Biol. 2006, 26 (24): 9377-86. 10.1128\/MCB.01229-06","journal-title":"Mol Cell Biol"},{"issue":"6981","key":"725_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature02371","volume":"428","author":"K Berns","year":"2004","unstructured":"Berns K, et al.: A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature. 2004, 428 (6981): 431-7. 10.1038\/nature02371","journal-title":"Nature"},{"issue":"6","key":"725_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nbt831","volume":"21","author":"AL Jackson","year":"2003","unstructured":"Jackson AL, et al.: Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 2003, 21 (6): 635-7. 10.1038\/nbt831","journal-title":"Nat Biotechnol"},{"key":"725_CR33","volume-title":"Wavelets and Filter Banks","author":"GN Strang","year":"1996","unstructured":"Strang GN, Truong : Wavelets and Filter Banks. 1996, Wellesley, MA, USA: Wellesley-Cambrage Press,"},{"issue":"52","key":"725_CR34","doi-asserted-by":"publisher","first-page":"36425","DOI":"10.1074\/jbc.M803603200","volume":"283","author":"PL Boulay","year":"2008","unstructured":"Boulay PL, et al.: ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells. J Biol Chem. 2008, 283 (52): 36425-34. 10.1074\/jbc.M803603200","journal-title":"J Biol Chem"},{"issue":"10","key":"725_CR35","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1158\/0008-5472.CAN-09-3739","volume":"70","author":"X Lu","year":"2010","unstructured":"Lu X, et al.: In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. Cancer Res. 2010, 70 (10): 3905-14. 10.1158\/0008-5472.CAN-09-3739","journal-title":"Cancer Res"},{"key":"725_CR36","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1017\/S1462399409001008","volume":"11","author":"H Nakshatri","year":"2009","unstructured":"Nakshatri H, Badve S: FOXA1 in breast cancer. Expert Rev Mol Med. 2009, 11: e8-","journal-title":"Expert Rev Mol Med"},{"issue":"9","key":"725_CR37","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1101\/gr.092833.109","volume":"19","author":"A Torkamani","year":"2009","unstructured":"Torkamani A, Schork NJ: Identification of rare cancer driver mutations by network reconstruction. Genome Res. 2009, 19 (9): 1570-8. 10.1101\/gr.092833.109","journal-title":"Genome Res"},{"issue":"2","key":"725_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/157489208784638785","volume":"3","author":"T Macarulla","year":"2008","unstructured":"Macarulla T, Ramos FJ, Tabernero J: Aurora kinase family: a new target for anticancer drug. Recent Pat Anticancer Drug Discov. 2008, 3 (2): 114-22. 10.2174\/157489208784638785","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"16","key":"725_CR39","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1158\/1078-0432.CCR-08-0746","volume":"14","author":"AC Mita","year":"2008","unstructured":"Mita AC, et al.: Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res. 2008, 14 (16): 5000-5. 10.1158\/1078-0432.CCR-08-0746","journal-title":"Clin Cancer Res"},{"issue":"9","key":"725_CR40","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1586\/14737140.8.9.1461","volume":"8","author":"S Rana","year":"2008","unstructured":"Rana S, et al.: Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther. 2008, 8 (9): 1461-70. 10.1586\/14737140.8.9.1461","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"725_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.tcb.2008.06.005","volume":"18","author":"I Peset","year":"2008","unstructured":"Peset I, Vernos I: The TACC proteins: TACC-ling microtubule dynamics and centrosome function. Trends Cell Biol. 2008, 18 (8): 379-88. 10.1016\/j.tcb.2008.06.005","journal-title":"Trends Cell Biol"},{"key":"725_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2407-6-96","volume":"6","author":"J Fridlyand","year":"2006","unstructured":"Fridlyand J, et al.: Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer. 2006, 6: 96- 10.1186\/1471-2407-6-96","journal-title":"BMC Cancer"},{"issue":"2","key":"725_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/geno.1999.5829","volume":"58","author":"IH Still","year":"1999","unstructured":"Still IH, Vince P, Cowell JK: The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines. Genomics. 1999, 58 (2): 165-70. 10.1006\/geno.1999.5829","journal-title":"Genomics"},{"issue":"3","key":"725_CR44","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1677\/ERC-07-0053","volume":"14","author":"S Ulisse","year":"2007","unstructured":"Ulisse S, et al.: Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues. Endocr Relat Cancer. 2007, 14 (3): 827-37. 10.1677\/ERC-07-0053","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"725_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1083\/jcb.200204155","volume":"158","author":"TA Kufer","year":"2002","unstructured":"Kufer TA, et al.: Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol. 2002, 158 (4): 617-23. 10.1083\/jcb.200204155","journal-title":"J Cell Biol"},{"issue":"11","key":"725_CR46","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1158\/0008-5472.CAN-07-0122","volume":"67","author":"PJ LeRoy","year":"2007","unstructured":"LeRoy PJ, et al.: Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity. Cancer Res. 2007, 67 (11): 5362-70. 10.1158\/0008-5472.CAN-07-0122","journal-title":"Cancer Res"},{"issue":"7186","key":"725_CR47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature06758","volume":"452","author":"V Emilsson","year":"2008","unstructured":"Emilsson V, et al.: Genetics of gene expression and its effect on disease. Nature. 2008, 452 (7186): 423-8. 10.1038\/nature06758","journal-title":"Nature"},{"key":"725_CR48","volume-title":"Stat Appl Genet Mol Biol","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S: A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005, 4: Article17,"},{"issue":"7","key":"725_CR49","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/pmic.200900380","volume":"10","author":"X Xu","year":"2010","unstructured":"Xu X, et al.: Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer. Proteomics. 2010, 10 (7): 1374-90. 10.1002\/pmic.200900380","journal-title":"Proteomics"},{"key":"725_CR50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ncomms1033","volume":"1","author":"J Li","year":"2010","unstructured":"Li J, et al.: Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun. 2010, 1: 34-","journal-title":"Nat Commun"},{"issue":"6","key":"725_CR51","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.cell.2010.11.013","volume":"143","author":"UD Akavia","year":"2010","unstructured":"Akavia UD, et al.: An integrated approach to uncover drivers of cancer. Cell. 2010, 143 (6): 1005-17. 10.1016\/j.cell.2010.11.013","journal-title":"Cell"},{"key":"725_CR52","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/msb.2011.17","volume":"7","author":"R Jornsten","year":"2011","unstructured":"Jornsten R, et al.: Network modeling of the transcriptional effects of copy number aberrations in glioblastoma. Mol Syst Biol. 2011, 7: 486-","journal-title":"Mol Syst Biol"},{"issue":"4","key":"725_CR53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng.350","volume":"41","author":"P Cahan","year":"2009","unstructured":"Cahan P, et al.: The impact of copy number variation on local gene expression in mouse hematopoietic stem and progenitor cells. Nat Genet. 2009, 41 (4): 430-7. 10.1038\/ng.350","journal-title":"Nat Genet"},{"issue":"5813","key":"725_CR54","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1136678","volume":"315","author":"BE Stranger","year":"2007","unstructured":"Stranger BE, et al.: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007, 315 (5813): 848-53. 10.1126\/science.1136678","journal-title":"Science"},{"issue":"8","key":"725_CR55","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrg2593","volume":"10","author":"PJ Hastings","year":"2009","unstructured":"Hastings PJ, et al.: Mechanisms of change in gene copy number. Nat Rev Genet. 2009, 10 (8): 551-64. 10.1038\/nrg2593","journal-title":"Nat Rev Genet"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-5-121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:34:10Z","timestamp":1630510450000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-5-121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1186\/1752-0509-5-121","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,1]]},"assertion":[{"value":"14 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"121"}}